Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

ELIXIR LABS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

ELIXIR LABS, INC.

via TERRAPIN STRATEGY, INC

1st Quarter (Jan 1 - Mar 31) · 2024Posted Apr 26, 2024Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: ELIXIR LABS, INC.
Description: AI
Location: Maryland · United States of America

Registrant

Firm: TERRAPIN STRATEGY, INC
Location: Arlington, Virginia, United States of America

Lobbying activities

1 issue

Government Issues
GSA Multiple Award Schedule
Lobbyistsmr JASON JACKSON FRYE
Covered position (mr JASON JACKSON FRYE): Tom Emmer MN 06 LD

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.